Status:
COMPLETED
The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Heart Failure
Eligibility:
All Genders
40-89 years
Brief Summary
Study to assess the risk of incident heart failure associated with the use of pramipexole compared with other dopamine agonists and additionally, to assess the risk of incident heart failure associate...
Eligibility Criteria
Inclusion
- All patients between 40 and 89 years of age who received at least one prescription for anti-parkinsonian drugs during the period 1997-2009
Exclusion
- Patients with a diagnosis of heart failure or with prescriptions for two or more among the digitalis, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blocker (ARB), and diuretic drug classes prior to cohort entry
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
26814 Patients enrolled
Trial Details
Trial ID
NCT02236741
Start Date
November 1 2009
Last Update
September 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.